Published: 2 December 2015
Author(s): Giuseppe Lippi, Gianfranco Cervellin
Section: Letter to the Editor

We read with interest the recent article of Bouzas-Mosquera et al., who investigated the impact effect of cardiac troponin I (cTnI) values on the frequency of myocardial ischemia and subsequent coronary events in patients with acute chest pain and biomarker concentration within the normal range [1]. The evidence emerged from this well structured study underpins a number of critical issues.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.